Try our Advanced Search for more refined results

Expert Analysis

Navigating DEA Quotas: Key To Psychedelics Industry Growth

By Kimberly Chew and Jaime Dwight ( November 6, 2025, 5:49 PM EST) -- A June 20 recommendation by a U.S. Drug Enforcement Administration judge advising the agency to proceed with its proposal to classify 2,5-Dimethoxy-4-iodoamphetamine, or DOI, into Schedule I brings a renewed urgency for psychedelics manufacturers to prepare for challenges....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies